Financials Allmed Medical Products Co.,Ltd

Equities

002950

CNE100003JM5

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
8.13 CNY +0.37% Intraday chart for Allmed Medical Products Co.,Ltd -0.97% -14.24%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 8,802 12,862 10,354 7,758 6,003
Enterprise Value (EV) 1 9,142 12,510 10,956 7,909 6,473
P/E ratio 26.3 x 11.1 x 24 x 19.1 x 54.4 x
Yield 2.88% 4.33% 1.28% 0.49% 0.28%
Capitalization / Revenue 3.74 x 3.35 x 3.54 x 1.84 x 2.18 x
EV / Revenue 3.89 x 3.26 x 3.75 x 1.88 x 2.35 x
EV / EBITDA 19.1 x 9.33 x 20.7 x 7.86 x 16.1 x
EV / FCF -39.1 x 13.7 x -155 x 7.93 x -17.6 x
FCF Yield -2.56% 7.31% -0.65% 12.6% -5.68%
Price to Book 4.29 x 4.42 x 3.76 x 2.5 x 1.88 x
Nbr of stocks (in thousands) 633,265 633,265 633,265 633,265 633,265
Reference price 2 13.90 20.31 16.35 12.25 9.480
Announcement Date 4/27/20 4/15/21 4/25/22 4/28/23 4/29/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,028 2,352 3,834 2,926 4,211 2,757
EBITDA 1 396.5 478.5 1,341 530 1,006 401.8
EBIT 1 285.8 357.7 1,200 387.6 817.1 180.7
Operating Margin 14.1% 15.21% 31.28% 13.25% 19.41% 6.55%
Earnings before Tax (EBT) 1 276.4 394.2 1,339 505.5 484.9 169
Net income 1 227.8 325.8 1,158 431.2 406.8 110.4
Net margin 11.23% 13.85% 30.19% 14.74% 9.66% 4%
EPS 2 0.4059 0.5295 1.828 0.6800 0.6424 0.1743
Free Cash Flow 1 -415.5 -233.6 914.3 -70.89 997.5 -367.4
FCF margin -20.49% -9.93% 23.84% -2.42% 23.69% -13.33%
FCF Conversion (EBITDA) - - 68.19% - 99.17% -
FCF Conversion (Net income) - - 78.98% - 245.22% -
Dividend per Share 2 0.1000 0.4000 0.8800 0.2100 0.0600 0.0270
Announcement Date 4/28/19 4/27/20 4/15/21 4/25/22 4/28/23 4/29/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 764 339 - 603 151 470
Net Cash position 1 - - 352 - - -
Leverage (Debt/EBITDA) 1.928 x 0.7092 x - 1.137 x 0.1504 x 1.169 x
Free Cash Flow 1 -415 -234 914 -70.9 998 -367
ROE (net income / shareholders' equity) 18.7% 19.2% 46.6% 15.2% 13.8% 3.29%
ROA (Net income/ Total Assets) 6.91% 7.38% 18.7% 4.91% 9.5% 2.08%
Assets 1 3,298 4,413 6,185 8,775 4,282 5,295
Book Value Per Share 2 2.340 3.240 4.600 4.350 4.900 5.030
Cash Flow per Share 2 0.5500 0.3800 2.060 1.070 0.8200 0.6300
Capex 1 287 233 243 291 398 286
Capex / Sales 14.16% 9.89% 6.34% 9.94% 9.45% 10.39%
Announcement Date 4/28/19 4/27/20 4/15/21 4/25/22 4/28/23 4/29/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002950 Stock
  4. Financials Allmed Medical Products Co.,Ltd